What does CUSIP 03969K108 represent in this 13F holders report?

CUSIP 03969K108 is the security identifier for ARQT - Arcutis Biotherapeutics, Inc. - Common used to aggregate holder disclosures.

How many institutions held ARQT - Arcutis Biotherapeutics, Inc. - Common in Q2 2023?

135 institutional investors reported ARQT - Arcutis Biotherapeutics, Inc. - Common for Q2 2023. Use the holders table for investor-level position and value details.

Arcutis Biotherapeutics, Inc. - Common (ARQT)

CUSIP: 03969K108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common
Shares outstanding: 123,318,907
Total 13F shares: 71,766,867
Share change: +166,027
Total reported value: $683,988,878
Put/Call ratio: 53%
Price per share: $9.53
Number of holders: 135
Value change: -$5,745,956
Number of buys: 90
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 03969K108?
CUSIP 03969K108 identifies ARQT - Arcutis Biotherapeutics, Inc. - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 03969K108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - Common (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7.4%	9,162,430	$100,786,730	—	31 Mar 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	7%	8,684,232	$95,526,552	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	3.7%	4,598,272	$50,580,992	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	2.9%	3,614,781	$39,762,591	—	31 Mar 2023	13F
Rubric Capital Management LP	13F	Company	2.8%	3,500,000	$38,500,000	—	31 Mar 2023	13F
Polar Capital Holdings Plc	13F	Company	2.5%	3,135,513	$34,490,643	—	31 Mar 2023	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	2.4%	3,000,000	$33,000,000	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	2.1%	2,582,131	$28,403,441	—	31 Mar 2023	13F
MARSHALL WACE, LLP	13F	Company	1.9%	2,305,336	$25,358,696	—	31 Mar 2023	13F
JENNISON ASSOCIATES LLC	13F	Company	1.8%	2,214,490	$24,359,390	—	31 Mar 2023	13F
Holocene Advisors, LP	13F	Company	1.7%	2,069,177	$22,760,947	—	31 Mar 2023	13F
ORBIMED ADVISORS LLC	13F 3/4/5	Company · 10%+ Owner	1.6%	1,914,479	$21,059,269	—	31 Mar 2023	13F 3/4/5
GW&K Investment Management, LLC	13F	Company	1.5%	1,904,722	$20,952,000	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	1.3%	1,656,065	$18,216,715	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	1.3%	1,628,500	$17,913,500	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.3%	1,621,774	$17,839,514	—	31 Mar 2023	13F
FRANKLIN RESOURCES INC	13F	Company	1.3%	1,593,370	$17,527,070	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	1.1%	1,330,065	$14,630,715	—	31 Mar 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.9%	1,114,111	$12,255,221	—	31 Mar 2023	13F
MIRABELLA FINANCIAL SERVICES LLP	13F	Company	0.04%	45,299	$9,849,004	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.69%	854,734	$9,402,074	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.66%	808,367	$8,892,040	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.56%	695,675	$7,652,425	—	31 Mar 2023	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.55%	679,391	$7,473,301	—	31 Mar 2023	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	0.46%	569,041	$6,259,451	—	31 Mar 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.41%	508,019	$5,577,846	—	31 Mar 2023	13F
Opaleye Management Inc.	13F	Company	0.41%	502,000	$5,522,000	—	31 Mar 2023	13F
Ensign Peak Advisors, Inc	13F	Company	0.39%	486,240	$5,348,640	—	31 Mar 2023	13F
AXA S.A.	13F	Company	0.36%	442,479	$4,867,269	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.36%	438,115	$4,819,085	—	31 Mar 2023	13F
EcoR1 Capital, LLC	13F	Company	0.34%	415,322	$4,568,542	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.31%	386,861	$4,255,471	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.27%	337,654	$3,714,194	—	31 Mar 2023	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.26%	317,152	$3,488,672	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.25%	304,706	$3,351,766	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.25%	302,502	$3,327,522	—	31 Mar 2023	13F
SEI INVESTMENTS CO	13F	Company	0.22%	273,599	$3,009,589	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.22%	271,521	$2,986,731	—	31 Mar 2023	13F
MPM BioImpact LLC	13F	Company	0.21%	254,137	$2,795,507	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.2%	246,976	$2,716,736	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.2%	243,999	$2,683,989	—	31 Mar 2023	13F
Parallax Volatility Advisers, L.P.	13F	Company	0.18%	226,313	$2,489,443	—	31 Mar 2023	13F
1492 Capital Management LLC	13F	Company	0.18%	223,516	$2,458,676	—	31 Mar 2023	13F
Centiva Capital, LP	13F	Company	0.16%	200,000	$2,200,000	—	31 Mar 2023	13F
AlphaCentric Advisors LLC	13F	Company	0.15%	190,000	$2,090,000	—	31 Mar 2023	13F
Neuberger Berman Group LLC	13F	Company	0.15%	183,015	$2,013,165	—	31 Mar 2023	13F
Saturn V Capital Management LP	13F	Company	0.14%	178,217	$1,960,387	—	31 Mar 2023	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.13%	162,830	$1,791,130	—	31 Mar 2023	13F
PDT Partners, LLC	13F	Company	0.13%	155,484	$1,710,324	—	31 Mar 2023	13F
Tekla Capital Management LLC	13F	Company	0.12%	148,874	$1,637,614	—	31 Mar 2023	13F

Institutional Holders of Arcutis Biotherapeutics, Inc. - Common (ARQT) as of Q2 2023

As of 30 Jun 2023, Arcutis Biotherapeutics, Inc. - Common (ARQT) was held by 135 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 71,766,867 shares. The largest 10 holders included FMR LLC, Frazier Life Sciences Management, L.P., STATE STREET CORP, Rubric Capital Management LP, JENNISON ASSOCIATES LLC, BlackRock Inc., Polar Capital Holdings Plc, Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, and MARSHALL WACE, LLP. This page lists 135 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

141

Q2 2023 holders

135

Holder diff

-6

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.